-
First Dietary Supplement Caucus briefing hosted for the 112th Congress
WASHINGTON — The congressional Dietary Supplement Caucus held its first briefing for the 112th Congress April 6 to a capacity crowd of 60 House and Senate staffers, the caucus announced Thursday.
The DSC recently was relaunched for the 112th Congress. The caucus serves as a bipartisan, bicameral group of members to facilitate discussions among lawmakers about the benefits of dietary supplements, provide tips and insights for better health and wellness, and promote research into the healthcare savings provided by dietary supplements.
-
Dr. Reddy's announces market launch of generic OTC Allegra
HYDERABAD, India — The Food and Drug Administration has approved Dr. Reddy's version of an allergy medication that recently received Rx-to-OTC switch approval, the generic drug maker said.
Dr. Reddy's fexofenadine HCl tablets are bioequivalent versions of Sanofi-Aventis’ Allegra, which received Rx-to-OTC switch approval from the FDA in January.
The fexofenadine HCl Rx market had branded and generic sales of approximately $452 million for the 12 months ended last December, according to IMS Health.